(Q39431665)

11 September 2017

title

Evaluation of a flow cytometry-based assay for natural killer cell activity in clinical settings (English)

1 reference

11 September 2017

1 reference

R Valiathan

1

1 reference

11 September 2017

J E Lewis

2

1 reference

11 September 2017

A B Melillo

3

1 reference

11 September 2017

S Leonard

4

1 reference

11 September 2017

K H Ali

5

1 reference

11 September 2017

D Asthana

6

1 reference

11 September 2017

publication date

1 April 2012

1 reference

Scandinavian Journal of Immunology

11 September 2017

published in

1 reference

11 September 2017

volume

75

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

455-462

1 reference

Keeping NK cells in highly regulated antiviral warfare

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Innate or adaptive immunity? The example of natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

New aspects of natural-killer-cell surveillance and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Measuring T cell-mediated cytotoxicity using fluorogenic caspase substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Natural killer cell cytotoxicity: a methods analysis of 51chromium release versus flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3083.2011.02667.X

10.1111/J.1365-3083.2011.02667.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference